
S.C. LG PHARM S.R.L.
Fiscal identifier: 22972425
Public procurement data for LG PHARM S.R.L. (22972425) from Romania. Explore the tenders this company has participated in, contracts won, and performance in the public procurement process.
Procurement Summary
LG PHARM S.R.L. is a company from Romania participating in public procurement. To date, the company has participated in 705 public tenders.
Data compiled and computed every hour from the company's tender participations.
| Title | Contracting authority | Value | Status | Result |
|---|---|---|---|---|
da35336099 Dacril 3/0 BX102 | RO SPITALUL ORASENESC DETA | RON 556.80 | Awarded | Won |
da35335996 DACRIL BX132 | RO SPITALUL ORASENESC DETA | RON 282.00 | Awarded | Won |
da35336240 BICRIL BX117 | RO SPITALUL ORASENESC DETA | RON 804.00 | Awarded | Won |
da35336148 BICRIL 2-0 BX107 | RO SPITALUL ORASENESC DETA | RON 627.60 | Awarded | Won |
da35336203 BICRIL BX112 | RO SPITALUL ORASENESC DETA | RON 741.60 | Awarded | Won |
da35335724 BICRIL BX119 | RO SPITALUL ORASENESC DETA | RON 336.00 | Awarded | Won |
da35336040 DACRIL BX128 | RO SPITALUL ORASENESC DETA | RON 268.80 | Awarded | Won |
da35335930 BICRIL BX103 | RO SPITALUL ORASENESC DETA | RON 268.80 | Awarded | Won |
da35335885 BICRIL BX104 | RO SPITALUL ORASENESC DETA | RON 140.76 | Awarded | Won |
da35335792 DACRIL BX123 | RO SPITALUL ORASENESC DETA | RON 295.20 | Awarded | Won |
da35335833 DACRIL BX131 | RO SPITALUL ORASENESC DETA | RON 321.60 | Awarded | Won |
da35335166 BICRIL 1 | RO SPITALUL ORASENESC DETA | RON 288.00 | Awarded | Won |
da35335251 Plasa chirurgicala 30cm x 30cm | RO Spitalul Clinic Municipal de Urgenta Timisoara | RON 720.00 | Awarded | Won |
da35336410 Husa camera | RO SPITALUL ORASENESC DETA | RON 330.00 | Awarded | Won |
da35336353 PIESA DE MANA SINGLE USE | RO SPITALUL ORASENESC DETA | RON 320.00 | Awarded | Won |
Related Links
Showing elements 226 - 240 out of 705 results.
Frequently asked questions
Monitor this company
Get notified when this company wins new tenders or participates in new opportunities.
Start tracking